129 related articles for article (PubMed ID: 7942805)
1. Hemolytic-uremic syndrome in a patient with chronic myelogenous leukemia treated with interferon alpha.
Schlaifer D; Dumazer P; Spenatto N; Mignon-Conte M; Brousset P; Lumbroso C; Cooper M; Muller C; Huguet F; Attal M
Am J Hematol; 1994 Nov; 47(3):254-5. PubMed ID: 7942805
[No Abstract] [Full Text] [Related]
2. Recombinant interferon alpha and hemolytic uremic syndrome: cause or coincidence?
Harvey M; Rosenfeld D; Davies D; Hall BM
Am J Hematol; 1994 Jun; 46(2):152-3. PubMed ID: 8172186
[No Abstract] [Full Text] [Related]
3. [Hemolitic uremic syndrome with hypertransaminasemia following treatment by interferon for chronic myeloid leukemia].
Denizon N; Beraud JJ; Mourad G; Blanc P; Bureau JP; Navarro M; Lavabre-Bertrand T
Gastroenterol Clin Biol; 2001 Nov; 25(11):1039-40. PubMed ID: 11845064
[No Abstract] [Full Text] [Related]
4. [Case of chronic myelogenous leukemia with hemolytic-uremic-syndrome like kidney during long-term interferon-alpha therapy].
Kobayashi H; Utsunomiya Y; Miyazaki Y; Tokutome G; Kawamura T; Hashimoto T; Sakai T; Takahashi S; Tojyo A; Asano S
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1259-61. PubMed ID: 9379108
[No Abstract] [Full Text] [Related]
5. Withdrawal of interferon-alpha results in prompt resolution of thrombocytopenia and hemolysis but not renal failure in hemolytic uremic syndrome caused by interferon-alpha.
Ohashi N; Yonemura K; Sugiura T; Isozaki T; Togawa A; Fujigaki Y; Yamamoto T; Hishida A
Am J Kidney Dis; 2003 Mar; 41(3):E10. PubMed ID: 12613003
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myelocytic leukemia.
Honda K; Ando A; Endo M; Shimizu K; Higashihara M; Nitta K; Nihei H
Am J Kidney Dis; 1997 Jul; 30(1):123-30. PubMed ID: 9214412
[TBL] [Abstract][Full Text] [Related]
7. 35-year-old patient with chronic myelogenous leukemia developing systemic lupus erythematosus after alpha-interferon therapy.
Mehta ND; Hooberman AL; Vokes EE; Neeley S; Cotler S
Am J Hematol; 1992 Oct; 41(2):141. PubMed ID: 1415177
[No Abstract] [Full Text] [Related]
8. Acute pancreatitis associated with interferon alpha therapy for chronic myelogenous leukemia.
Tannir NM; Talpaz M; Ghazal H; Proothi S; Kantarjian HM
Leuk Lymphoma; 2000 Nov; 39(5-6):647-50. PubMed ID: 11342349
[TBL] [Abstract][Full Text] [Related]
9. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
[No Abstract] [Full Text] [Related]
10. CML may not be part of HUS.
Lipton JH; Minden M
Am J Hematol; 1995 May; 49(1):100-1. PubMed ID: 7741131
[No Abstract] [Full Text] [Related]
11. Thrombotic microangiopathy associated with alpha-interferon therapy for chronic myeloid leukaemia.
Galesic K; Bozic B; Racic I; Scukanec-Spoljar M
Nephrology (Carlton); 2006 Feb; 11(1):49-52. PubMed ID: 16509932
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic thrombocytopenic purpura complicating chronic myelogenous leukemia treated with interferon-alpha. A report of two successfully treated patients.
Rachmani R; Avigdor A; Youkla M; Raanani P; Zilber M; Ravid M; Ben-Bassat I
Acta Haematol; 1998; 100(4):204-6. PubMed ID: 9973644
[TBL] [Abstract][Full Text] [Related]
13. Renal thrombotic microangiopathy induced by interferon-alpha.
Magee CC
Nephrol Dial Transplant; 2001 Oct; 16(10):2111-2. PubMed ID: 11572913
[No Abstract] [Full Text] [Related]
14. Thrombotic microangiopathy associated with interferon therapy for patients with chronic myelogenous leukemia: coincidence or true side effect?
Ravandi-Kashani F; Cortes J; Talpaz M; Kantarjian HM
Cancer; 1999 Jun; 85(12):2583-8. PubMed ID: 10375106
[TBL] [Abstract][Full Text] [Related]
15. Hemolytic-uremic syndrome during recombinant alpha-interferon treatment for hairy cell leukemia.
Stratta P; Canavese C; Dogliani M; Thea A; Degani G; Mairone L; Vercellone A
Ren Fail; 1993; 15(4):559-61. PubMed ID: 8210571
[TBL] [Abstract][Full Text] [Related]
16. Renal thrombotic microangiopathy associated with interferon-alpha treatment of chronic myeloid leukemia.
Magee CC; Abraham K; Farrell J; Dorman T; Walshe JJ
Am J Kidney Dis; 2000 Jul; 36(1):E5. PubMed ID: 10873904
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hemolytic anemia during alpha-interferon treatment in a patient with chronic myelogenous leukemia.
Stavroyianni N; Stamatopoulos K; Viniou N; Vaiopoulos G; Yataganas X
Leuk Res; 2001 Dec; 25(12):1097-8. PubMed ID: 11684283
[No Abstract] [Full Text] [Related]
18. Interferon-alpha-induced focal segmental glomerulosclerosis in chronic myelogenous leukemia: a case report and review of the literature.
Bremer CT; Lastrapes A; Alper AB; Mudad R
Am J Clin Oncol; 2003 Jun; 26(3):262-4. PubMed ID: 12796597
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia.
Yufu Y; Yamashita S; Nishimura J; Nawata H; Hirata J
Am J Hematol; 1994 Nov; 47(3):253. PubMed ID: 7942803
[No Abstract] [Full Text] [Related]
20. Thrombotic microangiopathy in a patient with chronic myelogenous leukemia on hydroxyurea.
Shammas F; Meyer P; Heikkila R; Apeland T; Gøransson L; Berland J; Kjellevold K
Acta Haematol; 1997; 97(3):184-6. PubMed ID: 9066715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
